Eva Doleželová
Impact in
- Obstetrics and Gynecology top 10%
- Pregnancy and preeclampsia studies
- Pharmacology top 10%
Papers in
- Anatomy 1
-
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Stanislav MičudaPetr NachtigalM HrochJolana CermanováFrantišek ŠtaudMartina ČečkováCarmelo BernabéuLukáš Červený
- Journals
- Atherosclerosis (3 papers)Physiological Research (2 papers)Life Sciences (2 papers)Scientific Reports (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- CzechiaSpainUnited States
In The Last Decade
Eva Doleželová
24 papers receiving 480 citations
Peers
Comparison fields: 5 of 76
- Obstetrics and Gynecology 63
- Pharmacology 53
- Oncology 137
- Biochemistry 35
- Endocrinology, Diabetes and Metabolism 65
Countries citing papers authored by Eva Doleželová
This map shows the geographic impact of Eva Doleželová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Doleželová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Doleželová more than expected).
Fields of papers citing papers by Eva Doleželová
This network shows the impact of papers produced by Eva Doleželová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Doleželová. The network helps show where Eva Doleželová may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eva Doleželová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2019 | 17 | |
| 3 | 2019 | 0 | |
| 4 | 2019 | 9 | |
| 5 | 2018 | 31 | |
| 6 | 2017 | 5 | |
| 7 | 2017 | 35 | |
| 8 | 2017 | 21 | |
| 9 | 2017 | 17 | |
| 10 | 2016 | 21 | |
| 11 | 2016 | 13 | |
| 12 | 2015 | 26 | |
| 13 | 2015 | 18 | |
| 14 | 2014 | 20 | |
| 15 | 2014 | 9 | |
| 16 | 2013 | 54 | |
| 17 | 2012 | 26 | |
| 18 | 2012 | 31 | |
| 19 | 2012 | 48 | |
| 20 | 2012 | 24 |
About Eva Doleželová
Eva Doleželová is a scholar working on Anatomy, Pharmacology, Endocrinology, Diabetes and Metabolism, Oncology and Biochemistry, having authored 26 papers that have together received 484 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Hormonal Regulation and Hypertension (6 papers), Nitric Oxide and Endothelin Effects (4 papers), Trace Elements in Health (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Iron Metabolism and Disorders (3 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Obstetrics and Gynecology (63 citations), Pharmacology (53 citations), Oncology (137 citations), Biochemistry (35 citations) and Endocrinology, Diabetes and Metabolism (65 citations). Eva Doleželová has collaborated with scholars based in Czechia, Spain and United States. Frequent co-authors include Stanislav Mičuda, Petr Nachtigal, M Hroch, Jolana Cermanová, František Štaud, Martina Čečková, Carmelo Bernabéu, Lukáš Červený, Ivana Němečková and Jana Rathouska. Their work appears in journals such as Atherosclerosis, Physiological Research, Life Sciences, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.